Head-to-head · WeighScore
BioGlow Health vs NuuVim
The verdict
BioGlow Health takes it — 69.2/100 to 68.2/100, but only just.
BioGlow Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BioGlow Health is a physician-supervised multi-vertical telehealth brand — weight loss, peptides, testosterone, ED and hair — that ships compounded medication to all 50 states with a free consultation and… NuuVim is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BioGlow Health | NuuVim |
|---|---|---|
| WeighScore | 69.2/100 | 68.2/100 |
| Grade | C | C |
| Scorecard rank | #129 | #153 |
| Semaglutide | $349/mo (compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | $169/mo (compounded) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #129 · C
Strengths
- Free consultation and free shipping nationwide
- Ships compounded GLP-1s to all 50 states
- Physician-supervised intake before any prescription
- One platform for weight loss plus peptides, testosterone, ED and hair
Where it loses points
- Premium pricing — compounded semaglutide starts higher than most competitors
- Sells retatrutide, an investigational molecule the FDA has not approved
- Prescribing clinicians and compounding-pharmacy partner not named
- No insurance accepted — cash-pay only
- Operating entity and credentials lightly disclosed
Graded #153 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.